Diagnosis and treatment of cholangiocarcinoma

[1]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[2]  A. Stiehl,et al.  Value of Brush Border Cytology for Dominant Strictures in Primary Sclerosing Cholangitis , 1999, Endoscopy.

[3]  D. Bluemke,et al.  MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. , 2001, AJR. American journal of roentgenology.

[4]  S. Hesse,et al.  Positron emission tomography with [18F]fluoro‐2‐deoxy‐D‐glucose for diagnosis and staging of bile duct cancer , 2001 .

[5]  R. Hruban,et al.  Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  M. Tempero,et al.  Radiochemotherapy and Transplantation Allow Long‐Term Survival For Nonresectable Hilar Cholangiocarcinoma , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  S. Hesse,et al.  Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. , 2001, Hepatology.

[8]  J. Soto,et al.  Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. , 2001, Radiology.

[9]  W. Bechstein,et al.  Extended resections for hilar cholangiocarcinoma. , 1999, Annals of surgery.

[10]  K. Boberg,et al.  Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation , 2002, Scandinavian journal of gastroenterology.

[11]  P. Johnson,et al.  Plasma nucleic acids in the diagnosis and management of malignant disease. , 2002, Clinical chemistry.

[12]  H. Thomas,et al.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998 , 2001, Gut.

[13]  M. Levy,et al.  Evaluation of the pancreaticobiliary ductal systems by intraductal US. , 2002, Gastrointestinal endoscopy.

[14]  G. Gores,et al.  Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. , 2002, Surgical oncology clinics of North America.

[15]  T. Therneau,et al.  Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. , 2001, Mayo Clinic proceedings.

[16]  T. Hwang,et al.  Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings , 2000, American Journal of Gastroenterology.

[17]  R. Felix,et al.  Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. , 2001, Gastrointestinal endoscopy.

[18]  A. Tannapfel,et al.  Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival , 2000, Hepatology.

[19]  A. Bergquist,et al.  Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.

[20]  G. D. De Palma,et al.  Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. , 2001, Gastrointestinal endoscopy.

[21]  M. E. Ryan,et al.  Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures. , 1994, Gastrointestinal endoscopy.

[22]  R. Lothe,et al.  Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma , 2001, International journal of cancer.

[23]  K. Endo,et al.  Cyclooxygenase-2 and ERBB-2 in Cholangiocarcinoma: Potential Therapeutic Targets , 2002, Seminars in liver disease.

[24]  M. Miyazaki,et al.  Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival , 2002, The British journal of surgery.

[25]  E. Fishman,et al.  Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging. , 1997, Critical reviews in diagnostic imaging.

[26]  G. Gores,et al.  Biliary tract cancers. , 1999, The New England journal of medicine.

[27]  K. Lillemoe,et al.  Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. , 2000, Journal of hepato-biliary-pancreatic surgery.

[28]  K. Boberg,et al.  Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. , 2000, Journal of hepatology.

[29]  J. Burdick,et al.  In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. , 1998, Gastrointestinal endoscopy.

[30]  Randall G. Lee,et al.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. , 1998, Annals of surgery.

[31]  M. Gonen,et al.  Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.

[32]  L. Blumgart,et al.  Hilar Cholangiocarcinoma: A Review and Commentary , 2000, Annals of Surgical Oncology.

[33]  M. Pruckmayer,et al.  The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. , 1998, European journal of cancer.

[34]  B. I. Choi,et al.  Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability , 2000, Abdominal Imaging.

[35]  S. Hansen,et al.  [Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography]. , 2000, Ugeskrift for laeger.

[36]  M. Manns,et al.  K-ras mutations in the bile of patients with primary sclerosing cholangitis , 2001, Gut.

[37]  N. Aronson,et al.  Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies. , 2002, Gastrointestinal endoscopy.

[38]  N. Soehendra,et al.  EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. , 2000, Gastrointestinal endoscopy.

[39]  M. Nagino,et al.  Lymph Node Metastasis from Hilar Cholangiocarcinoma: Audit of 110 Patients Who Underwent Regional and Paraaortic Node Dissection , 2001, Annals of surgery.

[40]  S. Kondo,et al.  Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  G. Gores,et al.  p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. , 2002, Gastroenterology.

[42]  K. Boberg,et al.  Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. , 2003, Journal of hepatology.

[43]  F. Prat,et al.  Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures , 2000, Gut.

[44]  C. Meyer,et al.  Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.

[45]  P. Kortan,et al.  Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. , 1996, Gastrointestinal endoscopy.

[46]  K. Sugano,et al.  Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. , 2001, Gastrointestinal Endoscopy.

[47]  T. Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[48]  S. Kondo,et al.  Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. , 2002, European journal of nuclear medicine and molecular imaging.

[49]  M. Ortner,et al.  Photodynamic therapy of nonresectable cholangiocarcinoma. , 1998, Gastroenterology.

[50]  G. Tytgat,et al.  Value of brush cytology for dominant strictures in primary sclerosing cholangitis , 1998, Endoscopy.